19 November 2015 - Long-awaited plans for the future of England’s Cancer Drugs Fund have now been unveiled, with proposals centred on a system for commissioning new cancer drugs that is fully integrated into NICE’s appraisal process.

For more details, go to: http://www.pharmatimes.com/Article/15-11-19/NICE_NHS_England_consult_on_Cancer_Drugs_Fund_revamp.aspx